SPOTLIGHT: Dabur gets nod for generic Camptosar

India's Dabur Pharma got the FDA's tentative OK to sell a generic version of Camptosar, Pfizer's colon cancer treatment. Report

Suggested Articles

Pfizer has scored FDA approval for its Humira biosimilar, but it can't launch the product for several years under a patent settlement.

The 3-2 vote on the deal was split along the party lines, spelling trouble for future biopharma M&A deals should Democrats move into the White House.

Recipharm has been building its capabilities in sterile injectable and inhalation drugs. Now it is buying a CDMO that manufactures devices for both.